SG11201408490PA - Virus filtration of cell culture media - Google Patents
Virus filtration of cell culture mediaInfo
- Publication number
- SG11201408490PA SG11201408490PA SG11201408490PA SG11201408490PA SG11201408490PA SG 11201408490P A SG11201408490P A SG 11201408490PA SG 11201408490P A SG11201408490P A SG 11201408490PA SG 11201408490P A SG11201408490P A SG 11201408490PA SG 11201408490P A SG11201408490P A SG 11201408490PA
- Authority
- SG
- Singapore
- Prior art keywords
- cell culture
- international
- culture medium
- vienna
- filtration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0017—Filtration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/26—Conditioning fluids entering or exiting the reaction vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M37/00—Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination
- C12M37/02—Filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Filtering Materials (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261662814P | 2012-06-21 | 2012-06-21 | |
| PCT/US2013/045663 WO2013192009A1 (en) | 2012-06-21 | 2013-06-13 | Virus filtration of cell culture media |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201408490PA true SG11201408490PA (en) | 2015-01-29 |
Family
ID=48672845
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201408490PA SG11201408490PA (en) | 2012-06-21 | 2013-06-13 | Virus filtration of cell culture media |
| SG10201701721TA SG10201701721TA (en) | 2012-06-21 | 2013-06-13 | Virus filtration of cell culture media |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201701721TA SG10201701721TA (en) | 2012-06-21 | 2013-06-13 | Virus filtration of cell culture media |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US9670456B2 (zh) |
| EP (2) | EP3103861B1 (zh) |
| JP (3) | JP6220392B2 (zh) |
| KR (2) | KR20190092618A (zh) |
| CN (2) | CN104640969A (zh) |
| AR (1) | AR092847A1 (zh) |
| AU (2) | AU2013277532B2 (zh) |
| BR (1) | BR112014031842B1 (zh) |
| CA (1) | CA2876473C (zh) |
| CO (1) | CO7151484A2 (zh) |
| DK (2) | DK3103861T3 (zh) |
| EA (2) | EA033006B1 (zh) |
| ES (2) | ES2601429T3 (zh) |
| HK (2) | HK1198335A1 (zh) |
| HR (1) | HRP20161435T1 (zh) |
| HU (1) | HUE031601T2 (zh) |
| IL (2) | IL236073B (zh) |
| IN (1) | IN2014DN10441A (zh) |
| MX (1) | MX347319B (zh) |
| MY (2) | MY195362A (zh) |
| NZ (1) | NZ629083A (zh) |
| PL (2) | PL3103861T3 (zh) |
| PT (2) | PT2732020T (zh) |
| SG (2) | SG11201408490PA (zh) |
| SI (1) | SI2732020T1 (zh) |
| TW (2) | TWI609962B (zh) |
| WO (1) | WO2013192009A1 (zh) |
| ZA (1) | ZA201409253B (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014DN10441A (zh) * | 2012-06-21 | 2015-08-21 | Baxter Int | |
| AR095196A1 (es) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| SG10201507931QA (en) | 2014-12-22 | 2016-07-28 | Emd Millipore Corp | Removal of microorganisms from cell culture media |
| JP7133925B2 (ja) | 2015-03-23 | 2022-09-09 | アレクシオン ファーマシューティカルズ インコーポレイテッド | ウイルス濾過 |
| EP3015542A1 (de) * | 2015-05-07 | 2016-05-04 | Bayer Technology Services GmbH | Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes |
| TW202330904A (zh) | 2015-08-04 | 2023-08-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
| US20190169559A1 (en) * | 2016-04-15 | 2019-06-06 | Boehringer Ingelheim International Gmbh | Cell retention device and method |
| US11034721B2 (en) * | 2016-12-09 | 2021-06-15 | Lonza Ltd | Method for the reduction of viral titer in pharmaceuticals |
| CA3067847A1 (en) * | 2017-07-06 | 2019-01-10 | Regeneron Pharmaceuticals, Inc. | Cell culture process for making a glycoprotein |
| TW202003832A (zh) * | 2018-05-04 | 2020-01-16 | 美商健臻公司 | 具有過濾系統的灌注式生物反應器 |
| US11504713B2 (en) * | 2019-03-11 | 2022-11-22 | Genzyme Corporation | Tangential viral filtration |
| WO2021231956A1 (en) * | 2020-05-14 | 2021-11-18 | North Carolina State University | Fast automated approach for the derivation of acellular extracellular matrix scaffolds from tissues |
| US20220106358A1 (en) * | 2020-10-02 | 2022-04-07 | Regeneron Pharmaceuticals, Inc. | Continuous virus retentive filtration |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0422874A (ja) * | 1990-05-16 | 1992-01-27 | Matsushita Electric Ind Co Ltd | 波形表示装置 |
| GB2352652A (en) | 1999-08-06 | 2001-02-07 | Fsm Technologies Ltd | Pre-treating hollow fibre membranes for micro-organism detection |
| US6485686B1 (en) * | 1999-09-17 | 2002-11-26 | The United States Of America As Represented By The Secretary Of The Army | Method and apparatus for counting submicron sized particles |
| WO2001040448A1 (en) | 1999-12-02 | 2001-06-07 | The General Hospital Corporation | Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon |
| US6485688B1 (en) | 2000-04-24 | 2002-11-26 | General Electric Company | On-line sparging sampling and monitoring systems and methods |
| US6630016B2 (en) * | 2002-01-31 | 2003-10-07 | Koslow Technologies Corp. | Microporous filter media, filtration systems containing same, and methods of making and using |
| US6835311B2 (en) | 2002-01-31 | 2004-12-28 | Koslow Technologies Corporation | Microporous filter media, filtration systems containing same, and methods of making and using |
| ES2214967B1 (es) * | 2003-03-06 | 2005-06-16 | Probitas Pharma, S.A | Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento. |
| EP1711513B1 (en) * | 2003-12-01 | 2014-07-02 | Novo Nordisk Health Care AG | Nanofiltration of factor vii solutions to remove virus |
| DE102005047301B4 (de) * | 2005-09-30 | 2009-04-16 | Sartorius Stedim Biotech Gmbh | Verfahren zum Nachweis der Virenabreicherung für die Validierung von Filtern und Filtrationsprozessen |
| US20070084788A1 (en) | 2005-10-14 | 2007-04-19 | Millipore Corporation | Ultrafiltration membranes and methods of making and use of ultrafiltration membranes |
| US8309029B1 (en) * | 2009-03-26 | 2012-11-13 | The United States Of America As Represented By The Secretary Of The Army | Virus and particulate separation from solution |
| US8945895B2 (en) * | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
| BR112012003802B1 (pt) * | 2009-08-20 | 2022-10-25 | Takeda Pharmaceutical Company Limited | Método para remover um vírus sem envelope lipídico de uma solução |
| IN2014DN10441A (zh) * | 2012-06-21 | 2015-08-21 | Baxter Int |
-
2013
- 2013-06-13 IN IN10441DEN2014 patent/IN2014DN10441A/en unknown
- 2013-06-13 EP EP16181886.9A patent/EP3103861B1/en active Active
- 2013-06-13 CN CN201380032998.7A patent/CN104640969A/zh active Pending
- 2013-06-13 WO PCT/US2013/045663 patent/WO2013192009A1/en active Application Filing
- 2013-06-13 BR BR112014031842-5A patent/BR112014031842B1/pt active IP Right Grant
- 2013-06-13 MX MX2014015950A patent/MX347319B/es active IP Right Grant
- 2013-06-13 DK DK16181886.9T patent/DK3103861T3/da active
- 2013-06-13 KR KR1020197022413A patent/KR20190092618A/ko not_active Application Discontinuation
- 2013-06-13 PT PT137310157T patent/PT2732020T/pt unknown
- 2013-06-13 CN CN201810569534.4A patent/CN108795724A/zh active Pending
- 2013-06-13 EA EA201590059A patent/EA033006B1/ru not_active IP Right Cessation
- 2013-06-13 SI SI201330369A patent/SI2732020T1/sl unknown
- 2013-06-13 KR KR1020157001269A patent/KR102008048B1/ko active IP Right Grant
- 2013-06-13 DK DK13731015.7T patent/DK2732020T3/en active
- 2013-06-13 ES ES13731015.7T patent/ES2601429T3/es active Active
- 2013-06-13 EP EP13731015.7A patent/EP2732020B1/en active Active
- 2013-06-13 NZ NZ629083A patent/NZ629083A/en unknown
- 2013-06-13 EA EA201990887A patent/EA201990887A1/ru unknown
- 2013-06-13 PT PT161818869T patent/PT3103861T/pt unknown
- 2013-06-13 JP JP2015518459A patent/JP6220392B2/ja active Active
- 2013-06-13 ES ES16181886T patent/ES2829968T3/es active Active
- 2013-06-13 MY MYPI2018000283A patent/MY195362A/en unknown
- 2013-06-13 CA CA2876473A patent/CA2876473C/en active Active
- 2013-06-13 PL PL16181886.9T patent/PL3103861T3/pl unknown
- 2013-06-13 SG SG11201408490PA patent/SG11201408490PA/en unknown
- 2013-06-13 SG SG10201701721TA patent/SG10201701721TA/en unknown
- 2013-06-13 AU AU2013277532A patent/AU2013277532B2/en active Active
- 2013-06-13 MY MYPI2014003498A patent/MY173835A/en unknown
- 2013-06-13 HU HUE13731015A patent/HUE031601T2/hu unknown
- 2013-06-13 PL PL13731015T patent/PL2732020T3/pl unknown
- 2013-06-19 TW TW102121710A patent/TWI609962B/zh active
- 2013-06-19 AR ARP130102198A patent/AR092847A1/es active IP Right Grant
- 2013-06-19 TW TW106136343A patent/TWI698522B/zh active
- 2013-06-19 US US13/921,417 patent/US9670456B2/en active Active
-
2014
- 2014-11-19 HK HK14111690.4A patent/HK1198335A1/zh unknown
- 2014-12-04 IL IL236073A patent/IL236073B/en active IP Right Grant
- 2014-12-15 ZA ZA2014/09253A patent/ZA201409253B/en unknown
- 2014-12-17 CO CO14277524A patent/CO7151484A2/es unknown
-
2016
- 2016-11-02 HR HRP20161435TT patent/HRP20161435T1/hr unknown
-
2017
- 2017-03-27 US US15/470,064 patent/US20170260498A1/en not_active Abandoned
- 2017-05-23 HK HK17105198.0A patent/HK1231502A1/zh unknown
- 2017-07-13 JP JP2017137031A patent/JP6557706B2/ja not_active Expired - Fee Related
- 2017-09-12 AU AU2017228547A patent/AU2017228547B2/en active Active
-
2018
- 2018-11-14 JP JP2018213613A patent/JP2019022526A/ja not_active Withdrawn
- 2018-12-04 IL IL263479A patent/IL263479B/en active IP Right Grant
-
2020
- 2020-03-12 US US16/816,641 patent/US11421202B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201408490PA (en) | Virus filtration of cell culture media | |
| SG11201408405WA (en) | Engineered three-dimensional connective tissue constructs and methods of making the same | |
| SG11201408777WA (en) | Degradable filter for smoking articles | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201406903SA (en) | Cell culture compositions and methods for polypeptide production | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201407819UA (en) | Improved methods of cell culture for adoptive cell therapy | |
| SG11201407876TA (en) | Wound dressing | |
| SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201407710VA (en) | Compositions comprising short-acting benzodiazepines | |
| SG11201908640TA (en) | Pyrrolidinones and a process to prepare them | |
| SG11201408821SA (en) | Selective pi3k delta inhibitors | |
| SG11201408221YA (en) | Microstructure-based wound closure devices | |
| SG11201407534PA (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
| SG11201807185UA (en) | Modified hyaluronic acid, method for making same and uses thereof | |
| SG11201901594RA (en) | Cell suspension for use in the treatment of lower extremity peripheral artery disease | |
| SG11201408123SA (en) | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof | |
| SG11201407680XA (en) | Membrane for filtrating water | |
| SG11201408808WA (en) | Method and system for treatment of biological tissue | |
| SG11201407405VA (en) | Method for identifying ligands of the ahr receptor having therapeutic sebosuppressive activity, and said ligands | |
| SG11201406787TA (en) | Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies | |
| SG11201407812SA (en) | Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives | |
| SG11201408396QA (en) | Improved resid hydrotreating catalyst containing titania | |
| SG11201407800SA (en) | Selective binding of biological targets to solid phase ureides |